stereotactic ablative body radiotherapy

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

stereotactic ablative body radiotherapy

May 3, 2024, 22:20 | Blog

Aren Karapetyan: Latest findings from Ontario revealing dynamic shifts in the management of Stage I NSCLC

Aren Karapetyan, Medical Resident at Yerevan State Medical University named after Mkhitar Heratsi and Secretary at…

Mar 25, 2024, 16:15 | Insight

Piotr Wysocki: Stereotactic ablative body radiotherapy of primary tumor is highly active in patients with localized renal cell cancer

Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…

All: 2 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023